% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Okafor:303971,
author = {E. O. Okafor and M. Bella-Omunagbe and T. Elugbadebo and T.
M. Dokunmu and E. F. Adebiyi$^*$},
title = {{T}argeting invasion-associated proteins {P}f{SUB}2 and
{P}f{TRAMP} in {P}lasmodium falciparum: identification of
potential inhibitors via molecular docking.},
journal = {BMC infectious diseases},
volume = {25},
number = {1},
issn = {1471-2334},
address = {London},
publisher = {BioMed Central},
reportid = {DKFZ-2025-01740},
pages = {1038},
year = {2025},
note = {#LA:B330#},
abstract = {Plasmodium falciparum subtilisin-like protease 2 (PfSUB2)
is responsible for processing Plasmodium falciparum
thrombospondin-related apical merozoite protein (PfTRAMP).
These proteins are essential for asexual blood stage growth
and RBC invasion and have, therefore, been identified as
potential drug targets. This study predicted the
three-dimensional structure of PfSUB2 and PfTRAMP and
identified potential inhibitors using molecular docking
methods. Five hundred nineteen compounds were docked against
both proteins with AutoDock Vina in PyRx. Compounds
139,974,934 and 154,414,021 exhibited better binding
affinities when compared to the standard inhibitors, PMSF,
which highlights them as suitable inhibitors and potential
antimalarials targeting PfTRAMP and PfSUB2. It also
highlights 155,204,487 as a compound with dual antimalarial
target potential, exhibiting a better binding affinity to
PfTRAMP and PfSUB2. The study recommends 139,974,934,
154,414,021, and 155,204,487 as possible compounds for
antimalarial drug development.},
keywords = {Plasmodium falciparum: physiology / Membrane Proteins:
antagonists $\&$ inhibitors / Membrane Proteins: chemistry /
Protozoan Proteins: antagonists $\&$ inhibitors / Protozoan
Proteins: chemistry / Subtilisins: antagonists $\&$
inhibitors / Subtilisins: chemistry / Molecular Docking
Simulation / Models, Chemical / Molecular Targeted Therapy /
Pharmacokinetics / Malaria, Falciparum: drug therapy /
Antimalarials: chemistry / Antimalarials: isolation $\&$
purification / Antimalarials: pharmacokinetics /
Antimalarials: pharmacology / Plasmodium falciparum (Other)
/ Malaria (Other) / Molecular Docking (Other) /
Subtilisin-like protease 2 (Other) / Thrombospondin-related
apical merozoite protein (Other) / PTRAMP protein,
Plasmodium (NLM Chemicals) / Membrane Proteins (NLM
Chemicals) / Protozoan Proteins (NLM Chemicals) / sub-2
protein, Plasmodium falciparum (NLM Chemicals) / Subtilisins
(NLM Chemicals) / Antimalarials (NLM Chemicals)},
cin = {B330},
ddc = {610},
cid = {I:(DE-He78)B330-20160331},
pnm = {312 - Funktionelle und strukturelle Genomforschung
(POF4-312)},
pid = {G:(DE-HGF)POF4-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40830840},
pmc = {pmc:PMC12366235},
doi = {10.1186/s12879-025-11380-w},
url = {https://inrepo02.dkfz.de/record/303971},
}